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GENETIC DISORDERS – DEVELOPMENT
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Renal renin-angiotensin system dysregulation caused by partial Partial bladder outlet obstruction during fetal life
bladder outlet obstruction in fetal sheep. causes significant kidney injury. Posterior urethral valves
Background. To determine whether fetal renal obstruction are a leading cause of end-stage renal failure before the
activates the renal renin-angiotensin system (RAS), an impor- age of two years and a significant cause of chronic renaltant mediator in normal kidney development and obstructive
failure throughout childhood and adolescence [1]. Renalnephropathy, we used a model of fetal partial bladder outlet
interstitial fibrosis is thought to be one of the importantobstruction (PBOO).
Methods. Total RNA and protein was extracted from kidney features of prenatal obstructive nephropathy. In many
of sheep fetuses with partial bladder outlet obstruction created postnatal kidney diseases, the renal renin-angiotensin sys-
at 95 days gestation, after 2 (N 5 6) and 5 weeks of obstruction tem (RAS) has been shown to play an important role in
(term; N 5 6), and from normal fetal sheep at various time the induction of renal interstitial fibrosis, possibly medi-
points between 60 and 135 days of gestation (total N 5 19).
ated through transforming growth factor-b1 (TGF-b1)Relative levels of mRNA for renin, angiotensinogen, type 1
[2]. Pharmacological manipulation of the RAS has beenand 2 angiotensin II (Ang II) receptors (AT-1 and AT-2),
shown to be beneficial in slowing the progression of renaland transforming growth factor-b1 (TGF-b1) were assessed by
semiquantitative reverse transcription-polymerase chain reac- fibrosis in animal models [3, 4] as well as human diseases
tion. Expression levels of AT-2 receptor protein were measured [reviewed in 5].
by Western blot analysis. The RAS has well-established physiological functions.
Results. Renin mRNA expression was increased (250%) Angiotensin II (Ang II) regulates blood pressure andafter two weeks of obstruction. In normal fetuses, AT-1 expres-
fluid and electrolyte balances, and it is also thought tosion was low at 60 to 75 days of gestation and increased toward
mediate renal growth and differentiation. The renal RASthe end of gestation, whereas AT-2 expression showed a reversed
pattern. At 109 days, PBOO caused an increased expression plays a crucial role during fetal kidney development. We
of AT-2 mRNA compared with normals (400%). Correspond- investigated the effects of fetal partial bladder outlet
ingly, AT-2 receptor protein was more abundant in obstructed obstruction on mRNA expression of critical elements of
kidneys. TGF-b1 mRNA expression was significantly increased the renal RAS. These elements include substrate, activat-in obstructed kidneys at 109 days gestation.
ing enzyme, and receptors for Ang II, angiotensinogen,Conclusions. These observations confirm the reciprocal de-
renin and the two major receptor subtypes, Ang II type 1velopmental regulation of AT-1 and AT-2 receptors’ expres-
(AT-1) and Ang II type 2 (AT-2), respectively. TGF-b1sion, suggesting their functional role in renal development.
Partial bladder outlet obstruction produces specific alterations: expression was investigated as a possible downstream
increased renin expression and altered balance of receptor mediator of Ang II-induced fibrosis, with the hypothesis
subtypes, which may induce altered functional and vascular that up-regulation of the renal RAS occurs with fetal
regulation of the obstructed fetal kidney. TGF-b1, a mediator
obstruction and may contribute to the initiation andof Ang II-induced fibrosis, may play a role in inducing and
propagation of renal fibrosis, as well as to alterations inpropagating interstitial fibrosis.
renal growth and differentiation [6, 7].
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anesthesia (halothane/oxygen after induction with keta- AAA GCG-39 (447 to 427). An approximate 523 bp
AT-2 product was amplified using the following primermine) in accordance with institutional animal care and
use guidelines. Surgical and anesthetic details have been pair: sense 59-TTC AAC CTA GCT GTG GCT GAC
TTA C-39 (109 to 133) and antisense 59-CCA TCT TCApublished previously [8]. The fetal hind end was exposed,
and the urachus was identified and occluded by a surgical GAA CTT GGT CAC GAG-39 (631 to 608). An approx-
imate 349 bp TGF-b1 product was amplified using theclip through a small incision at the base of the umbilical
cord. Additionally, in male sheep, the perineal urethra following primer pair: sense 59-GGC GAC CCA CAG
AGA GGA AAT AG-39 (620 to 643) and antisensewas mobilized, and an occluding gold jewelry ring (inter-
nal diameter of 2 mm) was placed around it. In female 59-AGG CAG AAA TTG GCG TGG TAG C-39 (968
to 947). Polymerase chain reactions (PCR) were per-sheep, the bladder neck was exposed via a suprapubic
midline incision, and the occluding gold jewelry ring was formed in a total volume of 25 ml, containing 22 ml of
PCR SuperMixt (GIBCO), 0.5 ml each of sense andplaced around the proximal urethra. All animals were
returned to the uterus, and pregnancy was allowed to antisense primer (20 pmol/ml), 0.1 ml of 32P dCTP (3000
Ci/mmol; Amersham, Arlington Heights, IL, USA) andcontinue. At 109 (N 5 6) and 135 days (N 5 6) of
gestation, animals were delivered via Cesarean section 2 ml of cDNA. PCR amplification was performed for
30 cycles at 948C (denature), 588C (anneal), and 728Cand were sacrificed. Normal, unmanipulated, and age
and sex-matched animals (total N 5 8) served as controls: (extend) for 40 seconds each. PCR products were sub-
jected to size separation by polyamide gel electrophore-usually twins of the obstructed animals. Additional nor-
mal sheep fetuses were sacrificed at 60, 75, 90 and 135 sis. Additional confirmation of PCR products was made
by sequence-specific restriction enzyme digest. All sam-days of gestation (total N 5 11 animals). Gross changes
in urinary tracts were assessed, and kidneys were rapidly ples were normalized to b-actin mRNA levels, and a
limiting dilution method was used to make semiquantita-retrieved, drained, and weighed. Representative whole
kidney samples were snap frozen in liquid nitrogen and tive comparisons. Band intensity was measured by scan-
ning densitometry according to manufacturer’s instruc-stored at 280 to 768C.
tions using a IS-1000 Digital Imaging System (version
Reverse transcription-polymerase chain reaction 2.00; Alpha Innotech, San Leandro, CA).
Total RNA extraction was performed using Tri-
Western blot analysisReagentt (Molecular Research Center, Cincinnati, OH)
according to the manufacturer’s instructions. Reverse Whole kidney samples were homogenized in lysate so-
lution with a polytron device. The lysate solution containstranscription (RT) was performed using MMLV-RT
(Ambion, Austin, TX, USA) with oligo-dT (GIBCO, Triton X-100 (5 ml/100 ml), 4-(2-aminoethyl)-bensenesul-
fonyl fluoride (0.125 mm), aprotinin (0.01 mg/ml), leu-Grand Island, NY, USA) as the first-strand primer.
cDNA was precipitated with linear acrylamide, ammo- peptin (0.01 mg/ml), ethylenediaminetetraacetic acid
(EDTA; 2 mm), and dithiothreitol (DTT; 5 mm) in 1 3nium acetate, and ethanol and was redissolved in sterile
water. Primers were selected from the previously pub- phosphate-buffered saline (PBS; all purchased from
Sigma Chemicals, St. Louis, MO, USA). Temperaturelished sheep angiotensinogen [9], sheep renin [10], sheep
AT-1 and AT-2 receptor [11], sheep TGF-b1 [12] and was maintained at 48C throughout the entire procedure.
The concentration of protein in each sample was deter-human b-actin [13], all found through GeneBank data-
base search. An approximate 350 bp b-actin product was mined using the Bio-Rad D C Protein Assay (Bio-Rad
Laboratories, Richmond, CA, USA). Equal amounts ofamplified using the following primer pair: sense 59-AAC
CGC GAG AAG ATG ACC CAG ATC ATG TTT-39 protein from each sample were then incubated with 10 ml
of anti-AT-2 receptor goat antibody (C-18; Santa Cruz(383 to 413) and antisense 59-AGC AGC CGT GGC
CAT CTC TTG CTC GAA GTC-39 (703 to 733). An Biotechnology, Santa Cruz, CA, USA) for one hour and
precipitated with 40 ml of Protein A/G Plus-Agaroseapproximate 201 bp angiotensinogen product was ampli-
fied using the following primer pair: sense 59-ACT TGT (Santa Cruz Biotechnology) overnight. As a negative
control, 10 ml of anti–AT-2 antibody was suspended inCCA CGG ACC CAA ATC-39 (717 to 737) and anti-
sense 59-TGG TGT TGT CCA CCC AGA ACT C-39 PBS and precipitated in the same manner as previously
described.(917 to 896). An approximate 370 bp renin product was
amplified using the following primer pair: sense 59-CTG The immunoprecipitates were then collected by cen-
trifugation at 2500 r.p.m. for five minutes. After washingGCA GAT CAG AAT GAA AGG G-39 (824 to 845)
and antisense 59-GAA CTT GCG GAT AAA GGT with PBS/1 m NaCl, the precipitates were resuspended
in electrophoresis buffer, which contains Tris-chloride,GGC-39 (1193 to 1173). An approximate 442 bp AT-1
product was amplified using the following primer pair: pH 6.8 (50 mm), 2% sodium dodecyl sulfate (SDS), 0.1%
bromophenol blue, DTT (67 mm), and 10% glycerol (allsense 59-TGG TGG GGA TAT TTG GAA ACA G-39
(6 to 27) and antisense 59-TGG GAT TCG TAA TGG purchased from Sigma Chemicals). Ten microliters of the
Gobet et al: Renal RAS and bladder obstruction1656
immunoprecipitates were subjected to size separation by
12% polyacrylamide gel electrophoresis in the presence
of SDS. The separated protein samples were then elec-
trotransferred to Immobilon P transfer membrane (Milli-
pore Corporation, Beford, MA, USA). Subsequently,
the membrane was washed, blocked with 10% Blotto
solution, and probed with a 1:1000 dilution of anti–AT-2
receptor antibody. The membrane was then incubated
with a secondary antibody, an anti-goat IgG-horseradish
peroxidase conjugate at a 1:40,000 dilution. Finally, the
bound secondary antibody was detected using the en- Fig. 1. Increased renin mRNA expression in two-weeks obstructed
versus normal kidneys of fetal sheep at 109 days of gestation, assessedhanced chemiluminescence (ECL) system (Amersham).
by semiquantitative RT-PCR. All samples were normalized to b-actinThe experiments were repeated using the antibody pre- mRNA levels. The representative gel from two independently per-
incubated with blocking peptide (BP) to confirm the formed experiments is shown.
specificity of the AT-2 receptor antibody.
Statistical analysis
toward the end of gestation (Fig. 2A). AT-2/AT-1 ratiosNumerical results between experimental groups were
were therefore high at 60 to 75 days of gestation andanalyzed for statistical significance within the same RT-
declined thereafter (Fig. 2B). Partial bladder outlet ob-PCR run, using the two-tailed alternate Welch t-test,
struction caused persistent high expression of AT-2which does not assume equal variances. All other data
mRNA in kidneys at 109 days gestation (400% of normal,were analyzed using Student’s t-test, with a P value ,0.05
P 5 0.007), whereas AT-1 mRNA expression levels wereindicating statistical significance.
unchanged in obstructed animals compared with controls
(Fig. 3A). The mean AT-2/AT-1 ratios at 109 days were
RESULTS therefore significantly increased compared with normal
At the time of sacrifice, all obstructed kidneys were kidneys (P 5 0.03; Fig. 3B). Similarly, AT-2 receptor
hydronephrotic and larger than normals. Kidney weight protein levels were increased in obstructed kidneys at 109
was increased at 109 days gestation in obstructed animals days (Fig. 4). At term, the mean AT-2/AT-1 ratios were
to a mean of 9.6 g/kidney (sd 5 1.51), significantly (P , not statistically significantly different (data not shown).
0.005) greater than 6.8 g/kidney (sd 5 0.63) in normal Transforming growth factor-b1 (TGF-b1) mRNA ex-
109-day-old fetuses. At term, kidney weight was signifi- pression was increased in obstructed kidneys at 109 days
cantly increased to a mean of 21.7 g/kidney (sd 5 15.3) gestation, but not at term (Fig. 3A).
in obstructed animals, whereas normals at term had a
mean weight of 9.1 g/kidney (sd 5 1.68, P 5 0.0007).
DISCUSSIONBladder weights at 109 days were increased in obstructed
Fetal partial bladder outlet obstruction causes signifi-animals to a mean of 4.1 g/bladder (sd 5 4.16). Normal
cant changes in gene expression of several componentsanimals had a mean bladder weight of 1.5 g/bladder (sd 5
of the renal RAS. Using semiquantitative RT-PCR, this0.29; NS P 5 0.39). At term, the mean bladder weight
study showed increased mRNA levels for renin, the acti-was 13.5 g/bladder (sd 5 12.7) in obstructed animals and
vating enzyme of the RAS, after two weeks of obstruc-2.9 g/bladder in normals (sd 5 0.65, P , 0.001). Mean
tion. Persistently elevated levels of angiotensin receptoranimal weights were equal in both groups at 109 days
type 2 mRNA in two-week obstructed fetal kidneys areas well as at term.
a novel finding in the context of obstructive nephropathy.At 109 days gestation, after two weeks of partial bladder
The precise function of AT-2 receptor is not known, butoutlet obstruction, renin mRNA expression was signifi-
it is well established that AT-2 is expressed in areas ofcantly increased in obstructed kidneys (230% of normal,
mesenchymal differentiation in many fetal tissues [14].P 5 0.009; Fig. 1). At this time point, angiotensinogen
Although AT-2 gene disruption studies have shown thatmRNA expression was detectable in all kidneys but was
AT-2 is not required for embryonic development [15,unchanged by partial bladder outlet obstruction. Renin
16], Ang II and AT-2 receptor are linked to growthmRNA expression in kidneys at term was similar in nor-
and differentiation processes as well as blood pressuremal and obstructed animals (data not shown).
regulation [reviewed in 17]. The increase in AT-2 geneIn normal fetuses, AT-1 mRNA expression was low
expression correlated with its increased protein levels inat 60 to 75 days of gestation and increased toward the
this study, indicating the potential functional significanceend of gestation. In contrast, AT-2 mRNA expression
was highly expressed at earlier time points and decreased of this effect.
Gobet et al: Renal RAS and bladder obstruction 1657
Fig. 2. Reciprocal regulation of angiotensin II (Ang II) receptor subtypes 1 and 2
(AT-1 and AT-2) mRNA expression during fetal kidney development from 60 to 135
days of gestation (term), assessed by semiquantitative RT-PCR. All samples were
normalized to b-actin mRNA levels. Representative results from a total of 19 samples
are shown (A). Densitometric analysis of ratios of AT-2/AT-1 receptor mRNA expres-
sion during normal fetal kidney development is shown in (B). *P , 0.03 vs. older
animals.
Fig. 3. (A) Semiquantitative RT-PCR analysis of TGF-b1 and Ang II receptor subtypes 1 and 2 (AT-1 and AT-2) mRNA levels in normal and
two-weeks obstructed kidneys at 109 days of gestation. All samples were normalized to b-actin mRNA levels. Increased AT-2 receptor gene and
TGF-b1 expression in two-weeks obstructed kidneys versus normal kidney was found. AT-1 expression was unchanged. The representative gel
from three independently performed experiments is shown in (A). Densitometric analysis of AT-2/AT-1 ratios is shown in (B). *P , 0.05 vs. older
animals.
In this study, using RT-PCR, the expression of mRNA RT-PCR analysis may have permitted angiotensinogen
mRNA detection. The second possibility—that mRNAfor all components of the renal RAS was found in the
developing sheep kidney. This is in agreement with sev- for angiotensinogen was amplified from an origin other
than renal—is not likely, as others found renal angioten-eral other reports that describe the fetal RAS in rat [18],
sheep [11, 19], and human [20] kidneys. In a previous sinogen expressed with a peak around birth in rat [22],
as well as sheep [23], fetuses using nonisotopic hybridiza-study using Northern blot analysis, no detectable renal
angiotensinogen expression during late gestation in fetal tion histochemistry. In our report, mRNA levels for an-
giotensinogen were unchanged by partial bladder outletsheep was found, but angiotensinogen was highly ex-
pressed in fetal liver [21]. The increased sensitivity of obstruction, possibly because of an abundance of this
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Fig. 4. Western blot analysis of angiotensin II receptor subtype 2 in normal and two-weeks obstructed kidneys at 109 days of gestation. The
representative gel of three independently performed experiments is shown (N 5 4 each gel). Ab, Increased AT-2 receptor protein expression in
two-weeks obstructed (O) kidney versus normal (N) kidney of fetal sheep at 109 days gestation assessed by Western blot analysis after immunoprecipi-
tation. Negative control (Neg). Ab 1 BP, specificity of AT-2 receptor antibody was confirmed by preincubating the Ab with blocking peptide
(BP). Band intensity of light chains from the antibody used for immunoprecipitation indicate equal protein loading.
substrate for the more tightly regulated expression of normal glomerular filtration rates but altered tubular
function [32]. Although the precise mechanisms of RAS-renin.
The critical role of the renin-angiotensin system in mediated regulation of renal development remain to be
defined, its critical role in kidney development is evidentkidney development and pathology has been demon-
strated in a variety of investigations [reviewed in 24, 25]. from these studies.
Changes in activity of the angiotensin receptors haveRenin is present in the renal vasculature during fetal
kidney development and changes to its mature, juxta- been shown to contribute to alterations in renal develop-
ment. Nullizygote mice for both AT-1 receptor subtypesglomerular cell localization during postnatal life [26].
This pattern suggests an important role of the RAS in AT-1a and AT-1b showed normal survival in utero but
decreased survival postnatally. Animals were growth im-renal vascular development. Fetal partial bladder outlet
obstruction induced increased levels of renal renin paired and hypotensive and showed abnormal kidney
morphology with delayed glomerular growth and matura-mRNA after two weeks of obstruction, which might sug-
gest adaptive vascular development. In neonatal rat kid- tion, hypoplastic papillae, and renal artery hypertrophy
[33]. In other studies, however, disruption of the murineneys, renin was identified not only in the juxtaglomerular
region but along the afferent arteriole in both obstructed Ang-II receptors AT-1a [34, 35], AT-1b [36], and AT-2
genes did not induce apparent renal pathology (abstract;and in the contralateral kidney exposed to unilateral
ureteral obstruction, again in a pattern resembling that Matsusaka et al, J Am Soc Nephrol 7:1602, 1996). AT-2
knockout mice did, however, have significant anomaliesof earlier stages in development [27].
Further evidence for a functional role of the RAS of the upper urinary tract, including the ureter and renal
pelvis [25].in normal kidney development has been provided by
pharmacological manipulations and targeted disruptions Gene expression of both Ang II receptor subtypes
(AT-1 and AT-2) in the fetal sheep was present withof RAS genes causing morphological as well as func-
tional abnormalities of the kidneys. Inactivation of an- reciprocal developmental regulation. This finding con-
firmed previous reports of developmental regulation ofgiotensinogen [28] and angiotensin-converting enzyme
(ACE) produced renal abnormalities in mice including renal AT-1 and AT-2 receptor gene expression [11, 19],
with increasing AT-1 and decreasing AT-2 message levels.hyperplastic arterial walls, papillary atrophy, tubular di-
lation, and interstitial fibrosis [29], similar to changes Using in situ hybridization, the authors localized AT-1
mRNA to presumptive mesangial cells of glomeruli inseen in the knockouts of both AT-1 receptor subtypes.
Renal functional studies in mice lacking ACE revealed 40-day gestation fetuses with continued expression in lambs
up to two days old. AT-1 mRNA was also found to beelevated urinary output, decreased urine osmolality, and
slightly elevated serum creatinine levels [30]. Pharmaco- expressed in medullary interstitial cells and in the cortical
medullary rays. AT-2 mRNA was found in epithelial cellslogical manipulation of the RAS in the developing kid-
ney in weanling rats with ACE inhibitors or AT-1 block- of the macula densa during nephrogenesis and in intersti-
tial cells surrounding developing glomeruli, but not iners results in similar histological changes, as described
in the ACE knockout mice. Further studies described the nephrogenic mesenchyme [19]. This finding would
suggest that the AT-1 receptor may mediate early differ-additional, striking vascular changes induced by Losar-
tan (AT-1 blocker) not readily detectable on conven- entiation events, whereas the AT-2 receptor may regulate
positioning of the macula densa at the vascular pole oftional histology, such as fewer distorted afferent arteri-
oles [31]. Functional studies in these animals showed its glomerulus. In fetal and postnatal weanling rats, AT-2
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Fig. 5. A hypothesis of the effects of partial
bladder outlet obstruction on the renal RAS,
and its effects on fetal renal growth, differenti-
ation, and regulation of extracellular matrix
deposition.
receptors in the nephrogenic zone of the metanephric through stimulation of TGF-b1 expression [reviewed in 2].
This mechanism would explain the previously describedrenal cortex and the advancing tubules and ampullae of
the ureteric bud were described [37, 38], indicating its renal interstitial fibrosis in prenatal obstructive uropathy
[46]. Figure 5 depicts our findings and summarizes thepossible role in renal morphogenesis by modulating cell
proliferation, and inducing apoptosis and early differen- known and discussed effects of RAS and the possible
interaction with TGF-b1 in the developing kidney ex-tiation of the nephron.
This concept of the AT-2 receptor as a regulator of posed to obstruction.
We have shown that partial bladder outlet obstructionrenal differentiation is supported by several in vitro cell
proliferation and differentiation assays. Ang II inhibits causes the immature pattern of angiotensin receptor gene
expression of early gestation (60 to 75 days) to persistbasic fibroblast growth factor-induced proliferation in
the R3T3 mouse embryonic fibroblast line that expresses into the last trimester of gestation. This finding raises
the possibility that the factors produced by obstructiononly the AT-2 receptor [39], and the density of mem-
brane AT-2 receptor in R3T3 cells responds to a variety (increased pressure, dilation, tubular stretch) are similar
to the driving forces during early development, causingof mitogenic and antiproliferative stimuli [40, 41]. Cell
differentiation processes have been attributed to Ang II renal growth and early differentiation of nephrons. Per-
sistence of the immature pattern of AT-2/AT-1 expres-stimulation via AT-2 receptor in neuroneal cell lines [42].
Ang II has been shown to induce apoptosis, mediated sion may be a compensatory response geared to adapt
the renal architecture to its altered functional demandsby the AT-2 receptor [43] in mouse embryonic fibroblasts
and in several other cell lines [44, 45]. In contrast, the in the setting of obstruction. Renal fibrosis induced by
obstruction is exaggerated in the AT-2 knockout mousepattern of AT-1 expression suggests a role in final differ-
entiation of the nephron and in mediating the classic [47]. This suggests another possible compensatory re-
sponse to the obstructive condition, whereby elevatedhemodynamic effects of Ang II [reviewed in 24]. This
body of evidence supports the view of the angiotensin AT-2 expression is maintained as a counterbalance to
fibrosis and collagen deposition induced by increasedreceptors acting as a regulatory system for Ang II activity
in early renal development and in response to obstruc- TGF-b1 activity. The developmentally regulated counter-
balance of the activities of the AT-1 and AT-2 receptorstion. In general, the AT-1 receptor subtypes act in a
growth-promoting manner, whereas AT-2 appears to act and its dysregulation by obstruction appears therefore
to be a potentially important factor in the pathophysiol-to promote differentiation.
Obstruction induces increased TGF-b1 expression, as ogy of congenital obstructive nephropathy and associ-
ated growth alterations, interstitial fibrosis, and hemody-shown in kidneys exposed to two weeks of obstruction.
Ang II is known to be a potent activator of fibrogenesis namic changes.
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